Lantheus

In News

US FDA approves Lantheus' new prostate cancer imaging formulation - Reuters

Reuters - Mar 06, 2026

Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection - Yahoo Finance

Yahoo Finance - Mar 06, 2026

FDA OKs new PYLARIFY TruVu scan to expand prostate cancer imaging - Stock Titan

Stock Titan - Mar 06, 2026

US FDA approves Lantheus’ new prostate cancer imaging formulation - WTVB

WTVB - Mar 06, 2026

US FDA approves Lantheus' new prostate cancer imaging formulation - TradingView

TradingView - Mar 06, 2026

FDA approves Lantheus’ PYLARIFY TruVu for prostate cancer imaging - Investing.com South Africa

Investing.com South Africa - Mar 07, 2026

Lantheus announces FDA approval of Pylarify TruVu (piflufolastat F 18) injection - marketscreener.com

marketscreener.com - Mar 06, 2026

Heron Bay Capital Management Acquires New Shares in Lantheus Holdings, Inc. $LNTH - MarketBeat

MarketBeat - Mar 06, 2026

Lantheus (LNTH) Gains FDA Approval for New Prostate Cancer Imagi - GuruFocus

GuruFocus - Mar 06, 2026

FDA Approves Lantheus’ PYLARIFY TruVu Injection for Detecting PSMA-Positive Lesions in Prostate Cancer - geneonline.com

geneonline.com - Mar 06, 2026

How Investors Are Reacting To Lantheus Holdings (LNTH) Tentative FDA Nod For PNT2003 Neuroendocrine Cancer Drug - simplywall.st

simplywall.st - Mar 06, 2026

Lantheus receives tentative FDA approval for its radio-equivalent to Lutathera - Radiology Business

Radiology Business - Mar 03, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment